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b-Secretase (BACE) is a transmembrane aspartyl pro-
tease, which generates the N terminus of Alzheimer’s
disease amyloid b-peptide. Here, we report that BACE
can be phosphorylated within its cytoplasmic domain at
serine residue 498 by casein kinase 1. Phosphorylation
exclusively occurs after full maturation of BACE by
propeptide cleavage and complex N-glycosylation. Phos-
phorylation/dephosphorylation affects the subcellular
localization of BACE. BACE wild type and an S498D
mutant that mimics phosphorylated BACE are predom-
inantly located within juxtanuclear Golgi compart-
ments and endosomes, whereas nonphosphorylatable
BACE S498A accumulates in peripheral EEA1-positive
endosomes. Antibody uptake assays revealed that rein-
ternalization of BACE from the cell surface is independ-
ent of its phosphorylation state. After reinternalization,
BACE wild type as well as BACE S498D are efficiently
retrieved from early endosomal compartments and fur-
ther targeted to later endosomal compartments and/or
the trans-Golgi network. In contrast, nonphosphorylat-
able BACE S498A is retained within early endosomes.
Our results therefore demonstrate regulated trafficking
of BACE within the secretory and endocytic pathway.
Alzheimer’s disease is the most common form of dementia
and is pathologically characterized by the invariant accumula-
tion of senile plaques and neurofibrillary tangles in certain
areas of the brains of Alzheimer’s disease patients (1). The
major constituent of senile plaques is the amyloid b-peptide
(Ab),1 which derives from the b-amyloid precursor protein
(bAPP) by endoproteolytic processing (2). b-Secretase cleaves
bAPP at the N terminus of the Ab-domain, resulting in the
generation of soluble APPS-b and a membrane-associated
C-terminal fragment bearing the complete Ab-domain. Subse-
quent cleavage of this fragment by g-secretase, which appears
to be identical with the presenilins, results in the release and
secretion of Ab (3).
Recently, an aspartyl protease with b-secretase activity was
identified in human embryonic kidney (HEK) 293 cells and was
initially called BACE (b-site APP-cleaving enzyme, Asp2, or
memapsin 2) (4–8) (Fig. 1A). A close homologue was also iden-
tified and termed as BACE-2, Asp1, DRAP, or memapsin 1 (4,
5, 9).2 Both enzymes are type I membrane proteins sharing
significant homology with other members of the aspartyl pro-
tease family (5–8). While BACE-2 is predominantly expressed
in peripheral tissues, BACE is highly expressed in neurons, the
major site of Ab generation. However, it appears that bAPP is
not the only substrate for BACE. In fact, mouse bAPP is a very
poor substrate for b-secretase activity (10). “Humanizing” the
Ab domain of mouse bAPP by three amino acid substitutions
resulted in efficient cleavage by b-secretase (10), suggesting
that bAPP may not be the exclusive substrate for BACE. How-
ever, other physiological substrates of BACE remain to be
identified.
BACE is cotranslationally modified by N-glycosylation and
further maturates by complex glycosylation as well as proteo-
lytic removal of its prodomain by a furin-like protease (11–14).
The majority of BACE molecules are localized within Golgi and
endosomal compartments, where they colocalize with bAPP (4,
5, 7, 12, 14). The acidic pH optimum of BACE (5–8) indicates
that it is predominantly active within late Golgi compartments
and/or endosomes/lysosomes. This is consistent with previous
findings demonstrating that b-secretase cleavage of bAPP can
occur in all of these acidic compartments (15–18).
It has recently been reported that BACE is reinternalized
from the cell surface to early endosomes and can recycle back to
the cell surface, a process that depends on a dileucine motif in
the cytoplasmic tail of BACE (14). This signal is located close to
a negatively charged domain, which contains a potential phos-
phorylation site. We found that BACE is indeed phosphoryl-
ated within its C-terminal domain and that the biological func-
tion of BACE phosphorylation resides in the regulation of the
retrieval of reinternalized BACE from endosomes.
MATERIALS AND METHODS
Cell Culture and Transfection—Human embryonic kidney (HEK) 293
and green monkey kidney COS-7 cells were cultured in Dulbecco’s
modified Eagle’s medium with Glutamax (Life Technologies, Inc.) sup-
plemented with 10% fetal calf serum (Life Technologies). The cell lines
stably overexpressing bAPP695 (19) and BACE carrying Myc epitopes at
the C terminus (12) have been described previously. Transfection of
cells with BACE cDNAs was carried out using Fugene reagent (Roche
Molecular Biochemicals) according to the supplier’s instructions. Single
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cell clones were generated by selection in 200 mg/ml zeocine
(Invitrogen).
cDNAs and Fusion Proteins—The phosphorylation site mutants of
BACE were generated by polymerase chain reaction techniques using
the appropriate oligonucleotides. The resulting polymerase chain reac-
tion fragments were subcloned into the EcoRI/XhoI restriction sites of
pcDNA3.1 containing a zeocine resistance gene (Invitrogen). To gener-
ate fusion proteins of gluthatione S-transferase and the cytoplasmic
domain of BACE, the sequence of BACE encoding amino acids 476–501
was amplified by polymerase chain reaction using appropriate primers.
The resulting fragments were subcloned into EcoRI/XhoI restriction
sites of pGEX-5X-1 (Amersham Pharmacia Biotech), and fusion pro-
teins were expressed in Escherichia coli DH5a and purified on GSH-
Sepharose according to the supplier’s instructions.
Antibodies, Metabolic Labeling, Immunoprecipitation, and Immuno-
blotting—The polyclonal antibodies 7523, 7520, and GM190 recognizing
the N terminus of BACE (amino acids 46–60), the C terminus (amino
acids 482–501), and the propeptide (amino acids 22–45), respectively,
have been described previously (12). Monoclonal a-giantin antibodies
and monoclonal a-bAPP antibodies were generously provided by Drs.
H.-P. Hauri and E. H. Koo, respectively. Monoclonal a-EEA1 antibody
was from Transduction Laboratories, and monoclonal antibody 9E10
developed by J. M. Bishop was obtained from the Developmental Stud-
ies Hybridoma Bank (University of Iowa).
To radiolabel cellular proteins, cells were incubated at 37 °C in
methionine-free serum-free medium for 45 min. Cells were then incu-
bated with the same medium supplemented with [35S]methionine/
[35S]cysteine (Promix; Amersham Pharmacia Biotech) and kept at 37 °C
for the times indicated in the respective experiments. For immunopre-
cipitations cells were lysed in buffer containing 1% Nonidet P-40 on ice
for 10 min. Lysates were clarified by centrifugation for 10 min at
14,000 3 g and immunoprecipitated for 3 h at 4 °C. After separation by
SDS-PAGE, proteins were transferred to PVDF membrane (Imobilon;
Millipore) and analyzed by autoradiography or phosphorimaging. Al-
ternatively, BACE was detected by immunoblotting using the enhanced
chemiluminescence technique (Amersham Pharmacia Biotech).
In Vivo Phosphorylation—HEK 293 cells were incubated 45 min in
phosphate-free media (Sigma). Media were aspirated, and the respec-
tive fresh media were added containing 18 MBq/ml [32P]orthophosphate
(Amersham Pharmacia Biotech). After 1 h at 37 °C, cells were incu-
bated for an additional 1 h in the presence or absence of protein kinase
activators/inhibitors or the phosphatase inhibitor okadaic acid at the
concentrations indicated in the respective experiments. To inhibit
N-glycosylation, cells were treated with 10 mg/ml tunicamycin for 2 h
prior to the addition of [32P]orthophosphate and during the labeling
period. After labeling, media were aspirated, and the cells were washed
twice with ice-cold PBS and immediately lysed on ice with lysis buffer
containing 1% Nonidet P-40 for 10 min. Cell lysates were centrifuged
for 10 min at 14,000 3 g, and supernatants were immunoprecipitated
with specific antibodies as indicated.
In Vitro Phosphorylation Assays—In vitro phosphorylation assays
were carried out as described previously (20). Recombinant rat casein
kinase (CK)-1 d (New England Biolabs), recombinant a-subunit of hu-
man CK-2 (New England Biolabs), and the catalytic subunit of protein
kinase A purified from bovine heart (gift from Dr. V. Kinzel) were used
for in vitro phosphorylation assays in a buffer containing 20 mM Tris,
pH 7.5, 5 mM magnesium acetate, 5 mM dithiothreitol. Protein kinase C
purified from rat brain (Biomol) was assayed in a similar buffer sup-
plemented with 1 mM phorbol 12,13-dibutyrate, 0.5 mM calcium chlo-
ride, and 100 mg/ml phosphatidylserine under mixed micellar condi-
tions. As substrates, fusion proteins of GST and the C terminus of
BACE (see above) were used. Phosphorylation reactions were started by
the addition of 10 mM [g-32P]ATP and allowed to proceed for 10 min at
32 °C. To control the kinase activities, parallel phosphorylation reac-
tions were carried out using phosvitin (1 mg/ml; Sigma) or histone (0.5
mg/ml; Sigma) as protein substrates. Reactions were stopped by the
addition of SDS sample buffer. Alternatively, cell extracts were used to
phosphorylate fusion proteins of GST and BACE. HEK 293 cells were
lysed in a buffer containing 20 mM Tris, pH 7.5, 5 mM magnesium
acetate, 5 mM dithiothreitol, and 0.5% Triton X-100. Lysates were
centrifuged for 10 min at 14,000 3 g, and fusion proteins of GST and
BACE-CT were added to the supernatant. Phosphorylation reactions
were started by the addition of [g-32P]ATP and allowed to proceed for 15
min in the presence or absence of 10 mM hymenialdisine (HD) and 1 mM
okadaic acid. GST fusion proteins were isolated by precipitation with
GSH-Sepharose (Amersham Pharmacia Biotech) for 2 h at 4 °C. Pre-
cipitates were washed five times with PBS and eluted by the addition of
SDS sample buffer and separated by SDS-gel electrophoresis.
Phosphoamino Acid Analysis—Phosphoamino acid analysis was car-
ried out by one-dimensional high voltage electrophoresis according to
Jelinek and Weber (21). Radiolabeled proteins, electrotransferred onto
PVDF membrane were hydrolyzed in 6 M HCl for 90 min at 110 °C.
Subsequently, supernatants were dried in a SpeedVac concentrator,
and pellets were dissolved in 8 ml of pH 2.5 buffer (5.9% glacial acetic
acid, 0.8% formic acid, 0.3% pyridine, 0.3 mM EDTA) and spotted onto
20 3 20-cm cellulose thin layer chromatography plates (Merck) together
with unlabeled phosphoamino acids (Ser(P), Thr(P), Tyr(P); 1 mg each;
Sigma). High voltage electrophoresis was carried out for 45 min at 20
mA. Radiolabeleled phosphoamino acids were localized by autoradiog-
raphy and identified by comparison with comigrating phosphoamino
acids after ninhydrine staining.
Deglycosylation Experiments—BACE was immunoprecipitated from
cell lysates as described above, and precipitates were incubated in the
presence of endoglycosidase H (endo H; Roche Molecular Biochemicals)
or PNGase F (Roche Molecular Biochemicals) for 14 h at 37 °C in the
appropriate buffer. Reactions were stopped by the addition of SDS
sample buffer, and reaction mixtures were separated by SDS gel
electrophoresis.
Immunocytochemistry—Cells stably expressing BACE cDNAs were
grown on polylysine-coated glass coverslips to 50–80% confluence. Cells
were fixed in 4% paraformaldehyde/PBS at room temperature and
processed for immunofluorescence as described previously (12). Bound
primary antibodies were detected by Alexa 488- or Alexa 594-conju-
gated secondary antibodies (Molecular Probes, Inc., Eugene, OR). In
some experiments, cells were incubated in the presence of 10 mg/ml
brefeldin A (BFA) for 30 min at 37 °C before fixation.
Antibody Uptake Assays—Cells grown on polylysine-coated glass cov-
erslips were washed twice with ice-cold PBS and incubated for 20 min
on ice in serum-free medium (Opti-MEM; Life Technologies, Inc.) con-
taining the indicated antibodies. Cells were then washed three times
with ice-cold PBS and subsequently incubated at 37 °C or 18 °C in
Dulbecco’s modified Eagle’s medium with Glutamax supplemented with
10% fetal calf serum for various time periods. After two washes with
PBS, cells were fixed in 4% paraformaldehyde/PBS and processed for
immunofluorescence.
Cells were analyzed using a Leica DMRB fluorescence microscope,
and photographs were taken with an RT monochrome spot camera
(Diagnostic Instruments) and processed with Metaview program (Vis-
itron Systems).
RESULTS
BACE Is Phosphorylated at Serine 498—To investigate
whether BACE is posttranslationally modified by phosphoryla-
tion, we used HEK 293 cells stably overexpressing human BACE.
HEK 293 cells were used previously to identify BACE in a func-
tional screening assay and to analyze its proteolytic function (7).
The same cell line was also used to successfully investigate the
effects of the Swedish bAPP mutation on b-secretase cleavage
(16), thus demonstrating that HEK 293 cells represent a valid
model system to study the cell biology of BACE.
After in vivo labeling with [32P]orthophosphate, cell lysates
were immunoprecipitated with antibody 7523 directed to an
N-terminal sequence after the prodomain (Fig. 1A). Analysis of
immunoprecipitated BACE by autoradiography revealed that
BACE undergoes phosphorylation (Fig. 1B). Incorporation of
[32P]orthophosphate is dependent on the presence of the phos-
phatase inhibitor okadaic acid (Fig. 1B). However, longer ex-
posure of the autoradiograms revealed weakly radiolabeled
BACE also in the absence of okadaic acid (data not shown). To
prove if BACE is phosphorylated within its cytoplasmic tail or
within its ectodomain as previously demonstrated for its sub-
strate bAPP (22–24), we generated a truncated derivative lack-
ing the cytoplasmic domain (BACEDC; Fig. 1A (12)). Although
high levels of BACEDC were expressed, the deletion of the
cytoplasmic tail of BACE completely abolished phosphorylation
(Fig. 1B). A soluble derivative of BACE lacking the transmem-
brane domain (12) is also not phosphorylated by cultured cells
(data not shown), further supporting the finding that the
ectodomain of BACE is not phosphorylated. These results
therefore demonstrate exclusive phosphorylation of BACE
within its cytoplasmic tail.
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Phosphoamino acid analysis of 32P-labeled BACE revealed
that it is phosphorylated on serine residues (Fig. 1C). The
cytoplasmic domain of BACE contains a single serine residue at
position 498 close to the C terminus (Fig. 1A). To confirm that
serine 498 is indeed phosphorylated in vivo, we generated a cell
line stably expressing BACE containing a serine to alanine
substitution (BACE S498A). This mutation completely blocks
phosphorylation of BACE, thus demonstrating that serine 498
is the sole in vivo phosphorylation site (Fig. 1D).
Phosphorylation Occurs Selectively after Full Maturation of
BACE—The results shown in Fig. 1 indicate that selectively
mature BACE (70 kDa) is phosphorylated but not the imma-
ture 66-kDa form of BACE. If that is the case, phosphorylated
BACE should be resistant to endo H treatment (12, 14). To
prove this, cells expressing BACE carrying a Myc tag at the C
terminus (12) were labeled with [32P]orthophosphate in the
presence of okadaic acid, and BACE was isolated from cell
lysates by immunoprecipitation with the a-Myc antibody 9E10.
Immunoprecipitates were incubated in vitro in the presence or
absence of endo H or PNGase F and separated by SDS-PAGE.
Immunoblot analysis with antibody 7523 revealed that endo H
deglycosylated exclusively the immature 66-kDa form of BACE
(Fig. 2A, left panel), consistent with the specificity of endo H for
immature, biantennary or high mannose, N-linked glycans. We
also identified the immature forms of BACE using antibody
GM190 directed against the prodomain (12) and found that
endo H selectively deglycosylates prodomain-containing imma-
ture forms of BACE (Fig. 2A, left panel). Autoradiography of
the same membrane revealed that phosphorylated BACE is
completely resistant to endo H treatment (Fig. 2A, left panel).
In contrast to endo H, treatment with PNGase F, which re-
moves all types of N-linked glycans, resulted in complete deg-
lycosylation of both phosphorylated mature and unphosphoryl-
ated immature BACE as demonstrated by a significant
molecular mass shift of 32P-labeled BACE from 70 to 50 kDa
(Fig. 2A, right panel). These results indicate that selectively
fully mature BACE is phosphorylated. To confirm this in living
cells, HEK 293 cells were labeled with [32P]orthophosphate in
the presence or absence of tunicamycin to inhibit cotransla-
tional N-glycosylation. BACE was immunoprecipitated with
the a-Myc antibody 9E10 and separated by SDS-PAGE. Con-
sistent with previous results (12), tunicamycin treatment
resulted in the accumulation of unglycosylated 50-kDa forms of
BACE (Fig. 2B). Detection with antibody GM190 demonstrates
accumulation of substantial levels of the unglycosylated prodo-
main-containing 50-kDa form of BACE after tunicamycin treat-
ment (Fig. 2B). Autoradiography of the same membrane re-
vealed that the unglycosylated form is not phosphorylated, in
contrast to the fully mature BACE at 70 kDa (Fig. 2B). Taken
together, these experiments demonstrate that phosphorylation
of BACE occurs selectively after full maturation by removal of
the prodomain and complex N-glycosylation.
FIG. 1. Phosphorylation of BACE at serine residue 498 within
the cytoplasmic domain. A, schematic of BACE. The aspartyl prote-
ase active site motifs (DTGS and DSGT) are indicated by asterisks. The
signal peptide (SP) is indicated by a black box, and the propeptide (pro)
is shown by a hatched box. The amino acid sequence of the cytoplasmic
domain is given in single letter code, and the phosphorylation site
(Ser498) is shown in boldface type. The epitopes of antibodies 7520, 7523,
and GM190 are indicated. B, HEK cells stably expressing wild-type
human BACE (WT) or a truncated derivative lacking the cytoplasmic
domain (DC) were labeled with [32P]orthophosphate in the presence or
absence of 0.2 mM okadaic acid (oa). BACE was isolated by immunopre-
cipitation, separated by SDS-PAGE, and transferred to a PVDF mem-
brane. Radiolabeled proteins were visualized by phosphorimaging (32P),
and BACE was detected by Western immunoblot with antibody 7523
(WB). Mature (m) and immature (im) forms of BACE are indicated by
arrowheads. C, phosphoamino acid analysis of radiolabeled BACE. The
arrowheads indicate migrations of standard phosphoamino acids
(P-Ser, P-Thr, P-Tyr) and origin of sample application (ori). D, phos-
phorylation of BACE WT and BACE S498A was analyzed as described
for B. Substitution of Ser498 by Ala completely abolished phosphate
incorporation.
FIG. 2. Selective phosphorylation of mature BACE. A, cells sta-
bly expressing BACE WT were labeled with [32P]orthophosphate in the
presence of 0.2 mM okadaic acid. BACE was isolated by immunoprecipi-
tation and incubated in the presence (1) or absence (2) of endo H or
PNGase F. Proteins were then separated by SDS-PAGE and trans-
ferred to a PVDF membrane. After detection of 32P-phosphorylated
BACE by phosphorimaging (32P), membranes were subjected to immu-
noblotting with antibody 7523. To specifically detect immature forms of
BACE, the same membrane was reprobed with antibody GM190 di-
rected against the prodomain. The phosphorylated form of BACE is
resistant to treatment with endo H, while it is sensitive to PNGase F. B,
HEK cells were incubated with [32P]orthophosphate in the presence of
0.2 mM okadaic acid and in the presence or absence of tunicamycin.
BACE was isolated by immunoprecipitation, separated by SDS-PAGE,
and transferred to a PVDF membrane. The membrane was first sub-
jected to autoradiography to visualize 32P-labeled proteins (32P) and
then probed with antibody 7523 and with antibody GM190. Note that
BACE is exclusively phosphorylated after full maturation by complex
N-glycosylation and proteolytic removal of its prodomain.
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Casein Kinase 1 Phosphorylates BACE—To identify a protein
kinase involved in phosphorylation of BACE, we first carried
out in vitro phosphorylation assays using fusion proteins of
GST with the cytoplasmic domain of BACE WT (CT-WT) or the
S498A mutation (CT-S498A). The fusion proteins were incu-
bated with four selected purified protein kinases in the pres-
ence of [g-32P] ATP. Since the phosphorylation site of BACE is
located within an acidic motif typical for substrate recognition
by CKs (25) (see Fig. 1A), we used CK-1 and CK-2 in initial
experiments. We also analyzed protein kinases A and C, since
these enzymes have been shown to affect endoproteolytic proc-
essing of bAPP (26–28). The fusion protein CT-WT was readily
phosphorylated by CK-1, while CK-2, protein kinase A, and
protein kinase C were not efficient (Fig. 3A, left panel), al-
though all kinases were catalytically active under the assay
conditions (Fig. 3B). CK-1-mediated phosphorylation of the
cytoplasmic domain of BACE was completely abolished when
CT-S498A was used as a substrate (Fig. 3A, right panels).
We next analyzed the involvement of CK-1 in the phospho-
rylation of BACE by cellular extracts. Lysates of HEK 293 cells
were incubated with [g-32P]ATP in the presence or absence of
HD, which preferentially inhibits CK-1, glycogen synthase ki-
nase 3b, and cyclin-dependent kinases (29), using the fusion
protein CT-WT as substrate. CT-WT was readily phosphoryl-
ated by the cellular extracts in the absence of HD (Fig. 3C). In
contrast, phosphorylation was completely blocked by HD. As
expected, the fusion protein CT-S498A and GST alone were not
phosphorylated by cellular extracts (Fig. 3C).
Phosphorylation of the Cytoplasmic Domain Affects the Sub-
cellular Localization of BACE—We next examined the subcel-
lular localization of BACE in stably transfected HEK 293 cells.
Cells grown on glass coverslips were fixed and costained with
polyclonal antibody 7523 against BACE and with monoclonal
antibody against giantin, a Golgi marker protein (30). BACE
WT and giantin partially colocalize in juxtanuclear structures
(Fig. 4, a and b). Consistent with previous results (4, 5, 7, 12,
14), additional staining was observed in juxtanuclear and ve-
sicular structures that did not overlap with the Golgi marker
giantin (Fig. 4, a and b). To prove whether this additional
staining is due to localization of BACE in post-Golgi compart-
ments, cells were treated with BFA for 30 min at 37 °C. BFA
treatment is known to result in the fusion of Golgi compart-
ments with the ER, while the trans-Golgi network (TGN) and
other post-Golgi compartments fuse with endosomes to form
vesicular/tubular structures (31). Treatment with BFA re-
sulted in reticular staining of giantin, indicative for a redistri-
bution of the Golgi marker protein giantin to the ER (Fig. 4d).
In contrast, BACE was detected in juxtanuclear and peripheral
vesicular structures after BFA treatment (Fig. 4c). These re-
sults indicate that BACE is not only localized in the ER and
Golgi but also in post-Golgi compartments.
To examine if phosphorylation of BACE affects its accumu-
lation in these compartments, we generated cDNA constructs
encoding BACE derivatives in which serine residue 498 is
substituted by alanine or by aspartate residues in order to
mimic unphosphorylated or phosphorylated BACE molecules,
respectively. HEK 293 cells stably expressing BACE WT,
BACE S498D, or BACE S498A were permeablized and
costained with antibody 7523 and antibodies against giantin.
As shown above (Fig. 4), BACE WT and giantin partially colo-
calize in juxtanuclear structures (Fig. 5, a and b). A very
similar localization was observed for BACE S498D, which
mimics phosphorylated BACE (Fig. 5, c and d). In contrast,
nonphosphorylatable BACE S498A showed less juxtanuclear
staining. Rather, BACE S498A accumulated in peripheral
vesicular structures near the plasma membrane, particularly
in cellular processes (Fig. 5e). Very similar data were obtained
with independent cell clones and transiently transfected HEK
293 cells (data not shown). These data indicate that some
aspects of subcellular sorting of BACE are affected by phospho-
rylation/dephosphorylation of serine residue 498.
To prove that the distinct staining pattern of the BACE
mutants is not simply due to impaired maturation, we per-
formed pulse-chase experiments. Immunoprecipitation with
antibody 7520 against the C terminus of BACE demonstrate
that the phosphorylation site mutants BACE S498A and BACE
S498D mature with similar kinetics as the WT protein by
complex N-glycosylation as indicated by the molecular mass
shift from 66 to 70 kDa (Fig. 6A, left panel). To analyze proteo-
FIG. 3. Casein kinase-1 phosphorylates BACE. A, fusion proteins
of GST carrying the WT (CT-WT; left panels) or the S498A mutant
(CT-S498A; right panels) cytoplasmic domain of BACE were incubated
with protein kinases CK-1, CK-2, A (PKA), and C (PKC) in the presence
of [g-32P]ATP. Reaction mixtures were separated by SDS-PAGE and
transferred to PVDF membrane. Phosphorylated fusion proteins were
detected by autoradiography (32P). The same membrane was stained
with Coomassie (Co) to control protein loading. B, the catalytic activi-
ties of CK-1 and CK-2 were assayed using 1 mg/ml phosvitin, and that
of protein kinase A was assayed with 0.5 mg/ml histone. The activity of
rat brain protein kinase C was controlled by detection of autophospho-
rylation. C, lysates of HEK 293 cells were incubated with fusion protein
CT-WT and [g-32P]ATP in the presence or absence of the CK-1-selective
inhibitor hymenialdisine (HD). As controls, the fusion protein CT-
S498A or GST alone were used as substrates. After the phosphorylation
reaction, fusion proteins were precipitated with GSH-Sepharose and
separated by SDS-PAGE. Phosphorylated fusion protein was detected
by autoradiography (32P). To prove equal loading, fusion proteins were
stained with Coomassie (Co). The arrowheads indicate migration of
GST fusion proteins. Hymenialdisine efficiently inhibits phosphoryla-
tion of CT-WT.
FIG. 4. Subcellular localization of BACE. HEK 293 cells stably
transfected with cDNAs encoding BACE WT were grown on glass cov-
erslips and incubated for 30 min at 37 °C in the presence (c and d) or
absence (a and b) of brefeldin A (10 mg/ml). Cells were fixed and
costained with the polyclonal antibody 7523 (a and c) and the mono-
clonal anti-giantin antibody (b and d). Note the difference in the redis-
tribution of BACE and giantin after BFA treatment. Bar, 10 mm.
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lytic cleavage of the prodomain of BACE, cell lysates were
immunoprecipitated with antibody GM190 directed against the
prodomain. Similar to our previous results (12), the prodomain
is predominantly observed in the immature 66-kDa BACE spe-
cies (Fig. 6A, right panel). The gradual disappearance of prodo-
main-containing forms indicates efficient maturation of BACE
S498A and BACE S498D similar to BACE WT (Fig. 6A, right
panel). Moreover, the mature 70-kDa forms of mutant BACE
S498A and S498D are both resistant to endo H cleavage, while
PNGase F efficiently deglycosylated the 70- and 66-kDa forms
(Fig. 6B). These data demonstrate that the mutations in the
cytoplasmic domain of BACE do not interfere with maturation
by complex N-glycosylation, indicating unimpaired forward
transport to late Golgi compartments and beyond. Therefore,
the altered subcellular localization of the nonphosphorylated
mutant BACE S498A is not due to impaired maturation.
Phosphorylation Regulates Retrieval of BACE from Endocy-
tosed Vesicles—Recently, it was reported that cell surface-lo-
cated BACE is internalized into endosomes (14). We therefore
first investigated whether phosphorylation of BACE might reg-
ulate its reinternalization from the cell surface. HEK 293 cells
stably expressing BACE WT or the phosphorylation site mu-
tant BACE S498A or BACE S498D were incubated for 20 min
on ice with antibody 7523 directed toward the ectodomain of
BACE. After removal of nonspecifically bound antibodies, cells
were returned to 37 °C for the time points indicated and pro-
cessed for immunocytochemistry. At time point 0 min, cells
expressing BACE WT or the S498D or S498A variants revealed
strong staining of the cell surface (Fig. 7, a, e, and i). In
contrast, untransfected HEK 293 cells were not labeled by
antibody 7523, demonstrating specific detection of exogenous
BACE at the cell surface (Fig. 7n). Staining of cells after 30 min
at 37 °C revealed that all BACE variants are efficiently inter-
nalized from the cell surface (Fig. 7, b, f, and k). Again,
untransfected cells were not stained, demonstrating that anti-
bodies were not internalized by fluid phase endocytosis (Fig.
7o). Staining cells after 1 and 2 h at 37 °C revealed significant
differences in the subcellular localization of internalized BACE
S498A as compared with BACE WT and BACE S498D. Cells
expressing BACE WT or the BACE S498D mutant that mimics
phosphorylated BACE revealed intensive juxtanuclear local-
ization indicative for late endosomal compartments and/or
TGN (Fig. 7, b–d and f–h). In contrast, the nonphosphorylated
mutant S498A showed predominant localization in vesicles
near the plasma membrane, which occasionally appeared to
accumulate in cellular processes (Fig. 7, k–m).
To identify the subcellular compartment to which BACE is
targeted after internalization from the cell surface, we per-
formed antibody uptake assays as described above. To detect
early endosomes, cells were costained with monoclonal antibod-
ies recognizing the early endosome antigen 1 (EEA1) (32).
Staining of cells after 15 min showed internalization of BACE
into some EEA1-positive compartments. No significant differ-
ences in the staining pattern between BACE WT and the phos-
phorylation site mutants (S498A and S498D) were detected at
this time point, demonstrating that internalized BACE is tar-
geted to early endosomal compartments independent of its
phosphorylation state (Fig. 8, a–f). After 30 min, internalized
BACE WT and BACE S498D were efficiently targeted to jux-
tanuclear structures (as described above; Fig. 8), showing less
colocalization with the EEA1-positive compartments (Fig. 8,
g–k). In contrast, the nonphosphorylated mutant BACE S498A
showed less pronounced accumulation in juxtanuclear struc-
tures (as described above) but appeared to be retained at least
partially in EEA1 positive endosomal compartments (Fig. 8, l
and m).
We next sought to identify the cellular trafficking step of
BACE, which is regulated by its phosphorylation. It was shown
previously that incubation of cells at 18 °C inhibits both for-
ward transport from the ER to Golgi and retrograde transport
from endocytosed vesicles to late endosomal compartments and
the TGN but allows endocytosis (33, 34). Cells were incubated
with antibody 7523 on ice as described above. After washing,
the cells were returned to 37 or 18 °C and incubated for an
FIG. 5. Phosphorylation state-dependent subcellular localiza-
tion of BACE. HEK 293 cells expressing BACE WT (a and b), the
mutant derivatives BACE S498D (c and d), or BACE S498A (e and f)
were grown on glass coverslips and then processed for immunocyto-
chemistry. After fixation, cells were costained with polyclonal antibod-
ies 7523 against BACE (a, c, and e) and monoclonal antibodies against
giantin (b, d, and f). Note that BACE WT and BACE S498D showed
similar subcellular distribution predominantly in juxtanuclear com-
partments (arrowheads) and partial colocalization with giantin. In con-
trast, BACE S498A revealed more vesicular staining in the periphery of
the cell (arrows). Bar, 10 mm.
FIG. 6. Substitution of serine residue 498 does not affect mat-
uration of BACE. A, pulse-chase experiments with cells expressing
BACE WT, S498A, and S498D. Cells stably expressing the respective
cDNAs were pulse-labeled for 10 min with [35S]methionine and chased
in the presence of excess amounts of unlabeled methionine for the time
points indicated. BACE was immunoprecipitated with antibody 7520
(left panel) or with antibody GM190 (right panel) and detected by
autoradiography. B, BACE S498A and S498D were isolated by immu-
noprecipitation from cells labeled with [35S]methionine and incubated
in the presence or absence of endo H or PNGase F. After separation by
SDS-PAGE, radiolabeled proteins were detected by autoradiography.
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additional 1 h. Internalized BACE was then detected with
fluorescence-labeled secondary antibody. After incubation at
37 °C, the above-described differences in the subcellular local-
ization of BACE WT, BACE S498D, and BACE S489A were
observed. While BACE WT and BACE S498D accumulated in
juxtanuclear compartments, BACE S498A was predominantly
localized in peripheral endocytosed vesicles (Fig. 9, a, c, and e),
identified as early endosomes (see Fig. 8). Costaining of these
cells with the monoclonal antibodies IG7/5A3 against bAPP
(35) revealed that internalized BACE WT and S498D partially
colocalized with its protein substrate bAPP in juxtanuclear
structures, while internalized BACE S498A showed less colo-
calization with bAPP (Fig. 9, a–f).
When cells were incubated at 18 °C, all variants of BACE
were readily internalized, but, in contrast to incubation at
37 °C, transport of reinternalized BACE WT and BACE S498D
to juxtanuclear structures was inhibited (Fig. 9, g and i).
Rather, at 18 °C all variants of BACE accumulated in periph-
eral vesicles, and BACE WT and S498D showed a very similar
localization as the nonphosphorylated S498A variant of BACE
(Fig. 9, g, i, and l). Costaining of these cells with bAPP anti-
bodies demonstrates that localization of bAPP in juxtanuclear
structures was not impaired under these experimental condi-
tions (Fig. 9, g–m).
FIG. 7. Phosphorylation regulates
intracellular trafficking of BACE.
HEK 293 cells stably expressing BACE
WT (a–d), BACE S498D (e–h), or BACE
S498A (i–m) or untransfected cells (n and
o) were incubated for 20 min with anti-
body 7523 on ice. Cells were washed and
incubated at 37 °C for the time points in-
dicated. Internalized antibodies 7523
were detected by Alexa 488-labeled anti-
rabbit secondary antibody. Bar, 25 mm.
FIG. 8. BACE is internalized from the cell surface into EEA1
positive early endosomes. HEK 293 cells stably expressing BACE
WT (a, b, g, and h), BACE S498D (c, d, i, and k), or BACE S498A (e, f,
l, and m) were incubated for 20 min with antibody 7523 on ice. Cells
were washed and incubated at 37 °C for 15 min (a–f) or 30 min (g–m)
before fixation. Internalized antibodies 7523 were detected by Alexa
488-labeled anti-rabbit secondary antibody (a, c, e, g, i, and l), and early
endosomal compartments were detected with monoclonal antibodies
against EEA1 (b, d, f, h, k, and m). Colocalization of BACE and EEA1
in early endosomal compartments is indicated by arrowheads (a–f, l,
and m), while juxtanuclear structures containing BACE WT (g) or
BACE S498D (i) are indicated by arrows. Bar, 10 mm.
FIG. 9. Phosphorylation-dependent retrieval of BACE from en-
docytosed vesicles. HEK 293 cells stably expressing BACE WT (a, b,
g, and h), BACE S498D (c, d, i, and k), or BACE S489A (e, f, l, and m)
were incubated for 20 min with antibody 7523 on ice. Cells were washed
and incubated at 37 °C (a–f) or 18 °C (g–m) for an additional 1 h. Cells
were fixed, and internalized antibodies were visualized with Alexa
488-labeled anti-rabbit secondary antibody. bAPP was detected with
monoclonal antibodies IG7/5A3 and Alexa 594-labeled anti-mouse sec-
ondary antibody. The arrowheads indicate juxtanuclear localization of
BACE WT and BACE S498D (a and c), and the arrows indicate local-
ization of BACE S498A in peripheral vesicles (e). Bar, 25 mm.
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In this study, we analyzed the subcellular trafficking of
BACE dependent on its phosphorylation state. A single phos-
phorylation site was identified by mutagenesis of serine resi-
due 498 in the C-terminal domain of BACE (Fig. 1A). By testing
several protein kinases in vitro, we found that CK-1 can phos-
phorylate BACE at the in vivo phosphorylation site at serine
residue 498. HD, which preferentially inhibits CK-1 beside
glycogen synthase kinase 3b and cyclin-dependent kinases
(29), significantly reduced phosphorylation of the cytoplasmic
domain of BACE in cellular extracts. The phosphorylation site
identified at serine residue 498 is preceded by a stretch of
acidic amino acid residues (Fig. 1A) representing a canonical
recognition motif for CK-1, but not for glycogen synthase ki-
nase 3b or cyclin-dependent kinases. Taken together, these
data indicate that CK-1 or a CK-1-like kinase is involved in the
phosphorylation of BACE in vivo. Phosphorylation occurs
exclusively on the fully maturated BACE after propeptide
removal and complex N-glycosylation. This indicates that phos-
phorylation of BACE takes place selectively after its exit from
the ER, presumably in Golgi or post-Golgi compartments. CK-1
occurs in several isoforms, and some have been shown to be
associated with the plasma membrane and synaptic vesicles
and to selectively phosphorylate a subset of membrane proteins
(36). CK-1 is implicated in the regulation of vesicular traffick-
ing in yeast presumably by phosphorylating components of
clathrin adaptor proteins (37, 38). Our data suggest that a
CK-1 isoform with a particular subcellular distribution (i.e. in
late Golgi and/or endosomal compartments) might be respon-
sible for the highly selective phosphorylation of mature BACE.
It has been reported that CK-1 is significantly elevated in
Alzheimer’s disease brains (39, 40). Moreover, Ab has been
shown to activate CK-1 in vitro (41). However, it remains to be
determined if phosphorylation of BACE is altered during
pathogenesis of Alzheimer’s disease.
In order to investigate the cellular function of phosphory-
lation/dephosphorylation on the trafficking of BACE, we
generated mutants in which the phosphorylation site at serine
residue 498 has been substituted by an alanine or an aspartate
residue to mimic nonphosphorylated and phosphorylated forms
of BACE, respectively. The major advantage of this strategy is
to circumvent the use of agents modulating kinase or phospha-
tase activities that might cause nonspecific or indirect effects
(42, 43). BACE carrying the S498D substitution was predomi-
nantly localized in juxtanuclear compartments, where it par-
tially colocalizes with the Golgi marker protein giantin. A very
similar distribution was observed for BACE WT, which is con-
sistent with previous results (7, 12, 14). In contrast, the non-
phosphorylated form BACE S498A showed less localization in
juxtanuclear structures but pronounced localization in vesicu-
lar compartments including EEA1 positive early endosomes. It
was demonstrated previously that the complete deletion of the
cytoplasmic domain of BACE results in its retention within the
ER and in impaired maturation (12). However, the phospho-
rylation site mutants BACE S498A and BACE S498D mature
normally by complex N-glycosylation and proteolytic removal of
the prodomain as compared with BACE WT. Therefore, the
significant differences in subcellular localization of the mutant
variants of BACE are due to distinct sorting. Consistent with
previous results (12, 14), we found that BACE is transported to
the cell surface and that BACE is internalized into EEA1-
positive early endosomal compartments. BACE WT as well as
the mutant derivatives S498A and S498D were efficiently en-
docytosed, indicating that phosphorylation of BACE does not
determine its reinternalization from the cell surface. Rather,
we found that phosphorylation of BACE is functionally re-
quired for efficient retrieval of the enzyme from early endo-
somes to later endosomal and/or TGN compartments from
which BACE might be recycled into the secretory pathway.
Interestingly, phosphorylation of reinternalized BACE af-
fected its colocalization with its protein substrate bAPP in
juxtanuclear structures. However, overexpressing BACE WT
or the phosphorylation site mutants led to increased secretion
of Ab as compared with untransfected control cell lines (data
not shown). This may reflect that expression of exogenous
BACE leads to saturated levels of Ab generation, regardless of
the differences in subcellular localization of the BACE vari-
ants. Indeed, previous studies demonstrated that bAPP could
be cleaved by b-secretase activity in distinct compartments,
including endosomes and late Golgi compartments (16, 17, 44).
We also demonstrate that reinternalization of BACE was not
affected by the S498A or S498D mutation. In addition, all
variants of BACE undergo normal maturation by complex
N-glycosylation. These data indicate that at least two major
sites of b-secretase activity, endosomes and secretory vesicles,
can be reached by BACE independent of its phosphorylation
state. However, it might be possible that regulation of subcel-
lular trafficking of endogenously expressed BACE by phospho-
rylation affects proteolytic processing of other, yet unknown,
protein substrates. In addition, we cannot yet exclude the pos-
sibility that phosphorylation may have subtle effects on bAPP
processing.
The regulatory mechanism of subcellular trafficking of
BACE is highly reminiscent to that of furin. Retrieval of furin
from endosomal to TGN compartments was also shown to be
dependent on phosphorylation/dephosphorylation of its cyto-
plasmic domain (45). Therefore, the subcellular localization of
BACE is regulated in a remarkably similar fashion like furin,
a protease that has recently been demonstrated to be required
for propeptide cleavage of BACE (11–13).
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